Connect with us

Cannabis

Medical Cannabis the cure for UK’s chronic pain issue

Published

on

One of the major issues of NHS right now is dealing with chronic pain patients. A recent study done by The British Pain Society disclosed that about 40 percent of the UK’s population suffers from chronic pain. This translates to about 26 million people that have been suffering from a pain that has lasted for longer than three months. It is about time the UK looks into its policy on Medical Cannabis.

Studies suggest that this percentage will only rise in the future. NHS is looking at about 60 percent of people suffering from chronic pain above the age of 75. The majority of the patients suffering from these issues just go from one prescription drug to the other with no favorable benefits. There are approximately 4.6 million appointments each year for this issue only. This issue also uses some of the major resources at NHS with about £69m in yearly cost.

The common treatment often directs patients to opioid painkillers. This is also an important issue. According to Public Health England, the UK has a dangerous growth rate in opioid use. The prescriptions are rising by 22% over the past decade. There are about 40 million prescriptions a year which shows how serious this issue is getting. NHS does prohibit patients from the consumption of opioid drugs as they can be addictive. In addition, they are looking for alternatives to opioid drugs.

One such alternative is the medical use of cannabis. UK law was amended in November 2018 to allow specialist doctors to prescribe a range of cannabis-based medicines to patients. Besides the law, there are very few instances of the use of medicinal treatments using cannabis. This is probably because of the complexities that exist in the process as well as the lack of study on the topic. A 2019 metric suggested that about 1.4 million people in the UK regularly use cannabis illegally for medicinal purposes. If the UK does legalize the treatment it can help a lot of people around the country.

Source: uofmhealth.org

Medical Cannabis, the alternative:

The UK’s pain problem has about 540,000 people nationwide addicted to opioids. With the percentage rising every year there is a dire need for THC-based alternatives. We currently need analgesics that are non-addictive and non-toxic at the same time. Interestingly, evidence from clinical trials showed the therapeutic benefits of medical cannabis. The cannabinoids have shown reducing effects on the neuropathic pain intensity in various studies until now

Take the US for example, the US government has made the medicinal use of cannabis legal for a while now. Consequently, the prescriptions for opioids and anti-depressants have dropped by around 30% in the country. Not only that the medical cannabis legalization and prescription have helped in reducing about 31% of deaths linked to opioids each year. Further analysis also shows that with the new laws in place the opioid prescriptions fell by 2.21 million daily doses filled per year.

All these metrics provide one simple piece of information, Cannabis-based alternatives have far more advantages when compared to conventional drugs. We have seen from the example of how America benefited from the legalization. Since it is a major issue in the UK as well, the government can’t put it aside for long.

The UK currently exports cannabis-based medicines to 48 countries worldwide where medical cannabis is legal. The country itself has only three cannabis medicines that are licensed for use after extensive clinical trials. Uk is still falling behind on Randomised Controlled Trials (RCTs) in the country which is an important step in legalization. However, those are expected to happen by 2021.

Consequently, as the chronic pain problem grows in the UK, we can expect NHS doctors to call for a change sooner or later.  They can not just continue to deny the patients proper cure because of the missing legal framework in the country. Hopefully, we will see a change in the system after proper research in the field.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Mayor To Cut the Ribbon on Cannabis ‘Cookies’ Inauguration

Published

on

Mayor To Cut the Ribbon on Cannabis 'Cookies' Inauguration

Michigan is seeing an increase in activities and businesses trading in marijuana. As the marijuana economy grows, Cookies is the newest store that opens its doors to Kalamazoo city. The Cookies cannabis store will be functional from Friday, Feb. 26.

The mayor for the city of Kalamazoo, David Anderson, is the chief guest for the ribbon-cutting ceremony. The store opening will be in the morning, according to the Cookies Cannabis Official press release. Also, the address for the store is 2712 Portage Street.

Medicinal Cannabis At The Curbside

The Cannabis Cookies store will not be offering curbside sales on its first day. For medicinal marijuana sales, curbside medical sales will be active from Saturday, Feb. 27, the press release further adds.

ALSO READ: Texas Med Store Starts Selling Cannabis-Infused Gummies As Medical Marijuana

Cookies is an international cannabis lifestyle brand founded by California rapper and entrepreneur, Berner.

Also, the Cookies brand is diverse and offers an entire family of offerings, including Cookies, Lemonnade, Runtz, Powerzzzup Genetics, Minntz, and Grandiflora product lines.

Expansion Plans

Cookies CEO Berner has high hopes for the Midwest. He thinks that stores like his will boost the marijuana economy and can support the economy even during slumps. Cookies has pinpointed the region as pivotal going forwards. The partnership with Gage Cannabis is also proving great for them as the demand for cannabis and medical marijuana is increasing day by day.

The expansion is driven by key partnerships and a high influx of consumers. Consumers are not only driving up demand in Kalamazoo but in the whole of Michigan. Cookies hopes to serve this rising demand as it strikes new partnerships throughout the region.

ALSO READ: Cannabis Antibiotics Can Be Solution For Treating Drug-Resistant Diseases 

The new store will be the second Cookies store in the state of Michigan. The original location where Cookies started operations last year is at 6030 East 8 Mile Road, in Detroit.
For the state of Michigan, Gage Cannabis is the go-to partner for the Cookies store. Through these key partnerships, the whole economy benefits as this will be Gage’s seventh retail point in Michigan state.
Continue Reading

Cannabis

Texas Med Store Starts Selling Cannabis-Infused Gummies As Medical Marijuana

Published

on

Marijuana Baked Products

As more and more states legalize cannabis use, dispensaries are finding new ways to morph cannabis into daily-use things. The popularity of medical marijuana is undoubtedly off the charts.  In another of such events, one of the state’s dispensaries now offers medical marijuana-infused gummies.

The Lone Star state is the second largest of all the states, falling behind Alaska. The fact that Elon Musk has set up his residence in the state has made it even more popular. Surterra Wellness, a well-known  Florida-based marijuana company, is also operating in Texas.  with a dispensary in Austin — launched its line of Surterra Wellness is bringing cannabis-infused lineup of edibles to cater to the needs of patients and cannabis consumers alike. This will provide patients with THC in a less intimidating form. The president of Surterra Wellness is positive about the impact this lineup of edibles can have.

Gummy Bears Carrying Marijuana

Mr. Ruark, the Surterra Wellness president, believes that the popularity of gummies makes them ideal to administer medicinal marijuana. Gummies are by far the most popular dosing form in medical markets across the United States. In addition to the popularity of gummies, they also contain terpenes. Terpenes provide a plethora of therapeutic properties and is an all natural extract.

ALSO READ: Cannabis Antibiotics Can Be Solution For Treating Drug-Resistant Diseases 

They also give medical marijuana users a new way of ingesting THC. The many flavors that gummy bears are available, make it a great option to use for the deliverance of medical marijuana.

Medicinal marijuana, although legal in Texas, is under extreme regulation and restrictions. Residents must opt into the Texas Compassionate Use Program that allows subscribers to use cannabis products for medicinal purposes. This programme was created in 2015 and is caters to patients of medical conditions such as epilepsy, seizures, terminal cancer, multiple sclerosis, incurable neurological disorders, autism and ALS.

Now, with the advancements in the way marijuana is covering ground, cannabis advocates in Texas are pressuring legislators to expand the program. There are expectations that the expansion will include patients suffering from PTSD.

Ruark believes that people are largely unaware of the medicinal programme in Texas. Also, he believes these gummies will change this. He thinks that his company can raise awareness about the state’s medical marijuana program.

Increasing The Cannabis Family by 2 Million

Increased reach will allow two million patients to use it who qualify for it even now but don’t use it because they don’t know about the program.

ALSO READ: International Market For Marijuana-Infused Drinks On The Rise

The president of the dispensaries wants everyone to benefit from the nature’s gift. He wants everyone to reap the benefits of cannabis. It may be of special benefit for veterans in dealing with PTSD after their return back to a normal life.

These lovely gummy treats come in a bottle that costs $60 and contains 200 milligrams of THC in total.

Continue Reading

Cannabis

Cannabis Antibiotics Can Be Solution For Treating Drug-Resistant Diseases 

Published

on

Cannabis Antibiotics

The cannabis plant contains multiple components of varying benefits, of which some constituents are psychoactive while others are non-psychoactive and have other pharmacological impacts. Because of the pharmacological benefits, researchers are working to formulate cannabis antibiotics.  

According to the research of The University of Queensland, CBD is a component present in marijuana, is non-psychoactive, and is capable of killing bacteria. It is useable in antibiotics due to its ability to kill bacteria responsible for gonorrhea, meningitis, and legionnaires. 

Moreover, according to studies, there is a possibility that drug-resistance diseases can cause more than 10 million deaths per year by 2050. The UN warns that there is an urgent need to deal with drug-resistant illnesses. Furthermore, finding solutions to the problems of drug resistance must be of utmost priority. 

ALSO READ: The Life of Marijuana Patients Made Easy By Advanced Technology

Drug resistance is growing, leading to critical problems shortly. According to neurologists, within five years, the NHS will successfully develop effective cannabis-antibiotics. Moreover, the treatment of drug-resistant diseases will be possible with the use of this marijuana containing antibiotics. 

Cannabis In Antibiotics

CBD is the cannabidiol, a major non-psychoactive and second-most prevalent component of the active ingredients of marijuana. Two institutions researched using cannabis in antibiotics. The institutions that collaborate for research are the University of Queensland and Botanix Pharmaceuticals Limited

In their research, researchers examined how the CBD of cannabis penetrates through the protective membranes of multiple bacteria. Moreover, not only does the CBD enter the bacteria, but it also kills them. 

Of the bacteria through which CBD penetrates are bacteria for meningitis, legionella, and Neisseria gonorrhea. The legionella bacteria cause legionnaire’s disease characterized by cough, shortness of breath, high fever, muscle pain, nausea, vomiting, and headache.

The researchers found that CBD was able to break down the biofilm of the bacteria. Biofilm is a slimy build-up of bacteria released by it to survive against antibiotic treatment. Moreover, the biofilm’s slimy layer is similar to a dental plaque on the surface.

What Is In The Future For Cannabis?

Cannabis-infused antibiotics may be available in the market. According to Professor Mike Barnes, pretty-soon general practitioners will start prescribing CBD pills to treat infectious diseases. Research on marijuana is progressing fast. Moreover, there are chances of formulating much better cannabis products for medicinal use. 

According to Mike Barnes, it is high time that individuals understand the medical benefits of marijuana and take advantage of the plant to its full capacity. Moreover, the marijuana plant is useable in various ways to improve the condition of patients. 

The new research led by the University of Queensland and Botanix Pharmaceutical Limited is helpful in the subject. However, further research is vital for developing much better, safer, and effective drugs containing CBD of marijuana.

More Studies Essential For A Better Future

According to Professor Mike Barnes, if CBD is placed next to bacteria in a plate, the cannabidiol will kill the bacteria right away. However, if a tablet containing CBD is on the same plate as the bacteria, the effect of CBD will be slower. 

ALSO READ: International Market For Marijuana-Infused Drinks On The Rise

The professor is confident that with further research on the subject, better medicine formulation can occur for treating drug-resistant diseases. Moreover, UK regulators can formulate something that can fight against antibiotic-resistant gonorrhea. Furthermore, the formation of antibiotics for drug-resistant gonorrhea is the utmost priority of the World Health Organization. 

Once the formulation of the cannabis-containing antibiotics is complete, the drugs will need the approval to conduct preclinical-trials and clinical trials. After completing the clinical trials and research investigations, the authorities will consider the drugs for approval after which they will be available in the market. 

Deep studies and research investigations enable the formulation of a more effective formulation. The quicker the cannabis containing antibiotics gets approval, the sooner they will be in the market for treating drug-resistant bacterial diseases. 

 

Continue Reading

Trending

error: Content is protected !!